Latest News

 Filter by Provider

(BPT) - When Stacy felt a familiar pain return to her arms, fingers and wrists, she knew something wasn't right.

Upstart stock fluctuated after results were released. Here's what the latest quarter means.

The market is worried about the end of the memory cycle.

Lockheed Martin's $58.6 billion PAC-3 award shows how America's rearmament push is turning defense spending into factory expansion.

Financial technology provider Fiserv (NASDAQ:FISV) announced better-than-expected revenue in Q3 2026, with revenue up 5.6% year on year to $5.20 billion. Its...

The healthcare stock may finally have the catalyst that it needs to take off before the end of the year.

HAUZ offers lower costs and higher yield, but ICF's concentrated U.S. portfolio delivered 8.4% returns versus a 6.9% loss over the past year.

Sandisk has been a top-performing stock this year, despite being down more than 50% from its 2026 highs.

Logistics and freight forwarding company Expeditors (NYSE:EXPD) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 41.9% ye...

Meta Platforms (then called Facebook) experienced a rocky first year on the market. Anthropic's stock could follow a similar post-IPO path.

Beverage company Keurig Dr Pepper (NASDAQ:KDP) met Wall Street’s revenue expectations in Q3 2026, with revenue up 70.6% year on year to $7.34 billion. On the...

After SpaceX's spectrum deal sparked a telecom sell-off, Verizon and T-Mobile's Q3 earnings beats and raised guidance suggest both carriers remain well-positioned against the emerging competitive threat.

CEO Bair delays profitability to Q2 2027 as mortgage rates hit 7.4%.

Teva stock advanced early Tuesday on better-than-expected third-quarter metrics and a raised outlook for 2026.

Healthcare services company Sotera Health (NASDAQ:SHC) beat Wall Street’s revenue expectations in Q3 2026, with revenue rising 4.4% year on year to $324.9 mi...

The recent correction in Alphabet stock creates a long-term buying opportunity for investors.

Fast-food company Yum! Brands (NYSE:YUM) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 3.8% year on year to $2.05 bill...

The company's growth rate accelerated to 96% in the third quarter.

Pfizer stock slipped a fraction early Tuesday, but the company raised its guidance for the year and named a new CFO.

CME commands a 62% net margin but trades at a higher sales multiple, while Interactive Brokers posts stronger free cash flow despite lower profitability.

Expanding into higher-margin components outside gas panels positions the company to convert revenue growth into outsized earnings gains.